Matthew Shinkle's profile photo

Matthew Shinkle

Voorhees Township, Woodbury

Associate Editor at The Sun Newspapers

Go Birds 🦅 Current - OCE @HemOncToday I Former - Sports Editor @sjsportsweekly, Associate Editor @VoorheesSun, @MedfordSun I @WaynesburgU grad

Articles

  • 2 days ago | healio.com | Matthew Shinkle

    James Ryan Mark, MD, FACS Receiving a prostate cancer diagnosis is often a pivotal moment in a patient’s life. Nearly all my patients, after discussing treatment options, either ask what dietary or lifestyle changes they can make to improve their outcomes or later share the changes they have already implemented, seeking my input.

  • 1 week ago | healio.com | Matthew Shinkle |Heather Biele

    Key takeaways: Chronic cutaneous immune-related adverse events often persist more than a year after discontinuation of immune checkpoint inhibitor therapy. The findings highlight the importance of dermatology referral. Cutaneous immune-related adverse events that develop after immune checkpoint inhibitor therapy become chronic in nearly one-quarter of cases, according to a research letter published in JAMA Dermatology.

  • 1 week ago | healio.com | Matthew Shinkle |Heather Biele

    Key takeaways: Exercise 3 days per week improved sexual function for men with prostate cancer vs. usual care. Exercise also improved fat mass and muscle strength. Exercise improved erectile dysfunction compared with standard care among men with prostate cancer, according to study results published in JAMA Network Open. Men who are concerned about sexual dysfunction should be offered exercise as a potential rehabilitation strategy after treatment, researchers concluded.

  • 1 week ago | healio.com | Matthew Shinkle |Heather Biele

    Key takeaways: Approximately 25% of patients had ctDNA- or imaging-confirmed recurrence. More than 30% had evidence of recurrence by imaging that ctDNA did not identify. The addition of serial circulating tumor DNA assays to imaging surveillance offered little benefit to patients with stage II to stage IV colorectal cancer who underwent curative-intent resection, according to study results. Nearly one-third of patients had evidence of recurrence by imaging that ctDNA did not identify.

  • 2 weeks ago | healio.com | Matthew Shinkle

    Key takeaways: Biomarker testing appeared inconsistent, with rates not reflecting guidelines. Less than 25% of oncologists reported feeling “very” or “extremely” comfortable interpreting or applying biomarker test results. Less than one-quarter of oncologists surveyed indicated that every one of their patients with advanced gastric or gastroesophageal junction cancers received biomarker testing consistent with practice guidelines.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
627
Tweets
3K
DMs Open
No
Matthew Shinkle
Matthew Shinkle @Mgshinkle24
10 Apr 25

RT @ScottHanson: 150 Days until RedZone

Matthew Shinkle
Matthew Shinkle @Mgshinkle24
9 Apr 25

RT @TheGoodPhight: 462 feet and 116 mph later…. https://t.co/IZ8lDj1gm5

Matthew Shinkle
Matthew Shinkle @Mgshinkle24
7 Apr 25

RT @CalltoActivism: This is absolutely insane. WTAF. https://t.co/iKYAfdt4Oy